FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented: using hyaluronidase for preventing and/or treating arterial hypertension, a related method of treating or preventing arterial hypertension. There are also presented a formulation, a combined preparation and a pharmaceutical composition for preventing and/or treating arterial hypertension, containing hyaluronidase and at least one antihypertensive additive, and a method of preventing and/or treating arterial hypertension using them.
EFFECT: what is shown is achieving the declared application after the independent administration of hyaluronidase intensifying the hypotension action of angiotensine II inhibitors, a calcium channel antagonist, an ATP antagonist and combinations of anti-hypertension agents.
16 cl, 10 tbl, 4 ex
